Skip to main content

Table 1 Demographics and baseline characteristics

From: Rates of glaucomatous visual field change before and after transscleral cyclophotocoagulation: a retrospective case series

 

Mean (No)

SD

Median

Min

Max

Age (years)

67.7

14.1

68.8

12

88

Gender Female (%)

23 (50)

    

Eye right (%)

27 (59)

    

Treatment per eye

1.2

0.5

1

1

3

No. of preoperative VFs

5.5

3.3

5

2

14

No. of postoperative VFs

3.6

1.7

3

2

8

Last preop VF to surgery (days)

243.4

303.0

128

7

1421

Surgery to first postop VF (days)

273.2

138.6

269

16

596

Retreatment (%)

20

    

Follow-up preoperative (years)

3.6

2.8

3

0.2

9.9

Follow-up postoperative (years)

2.1

1.4

1.7

0.4

5.8

IOP preoperative

23.2

4.7

23

14.4

33.2

IOP postoperative

14.3

3.2

14.1

8

22

No. of AGM preop.

3

1.5

3

0

6

No. of AGM postop.

2.44

1.42

3

0

6

BCVA preoperative

0.16

0.56

0.1

2.9

0

BCVA postoperative

0.22

0.52

0.15

2.9

−0.1

Phakic at the time of surgery (%)

23 (50)

    

Surgical treatment before FU (%)

37 (80)

    

– Trabeculectomy (%)

18 (39)

    

– ELT (%)

4 (9)

    

– SLT (%)

3 (6)

    

– ALT (%)

4 (9)

    

– Tube shunt (%)

2 (4)

    

– Deep sclerectomy (%)

5 (11)

    

– YAG–laser iridotomy (%)

1 (2)

    
  1. IOP, intraocular pressure in mmHg; AGM, antiglaucoma medications; BCVA, best–corrected visual acuity in logMAR; FU, follow–up; Preop, preoperative; Postop, postoperative; ELT, Excimer laser trabeculoplasty; SLT, Selective laser trabeculoplasty; ALT, Argon laser trabeculoplasty